MOP-3 inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of MOP-3, also known as BMAL1, a key transcription factor involved in the regulation of circadian rhythms. MOP-3/BMAL1 forms a heterodimer with CLOCK, another core circadian protein, and this complex drives the expression of various clock-controlled genes that regulate physiological processes in a 24-hour cycle. MOP-3 plays a pivotal role in maintaining the circadian clock by activating the transcription of genes that control metabolic, sleep-wake, and immune system functions. It acts by binding to E-box elements in the promoter regions of its target genes, regulating their expression in a time-dependent manner. By inhibiting MOP-3, researchers can interfere with this transcriptional regulation, offering a tool to study the specific role of MOP-3 in circadian rhythm regulation and the downstream physiological effects.
In research settings, MOP-3 inhibitors are useful for exploring the molecular mechanisms of the circadian clock and its influence on various biological processes. Inhibition of MOP-3 disrupts the normal feedback loops that maintain circadian oscillations, allowing scientists to investigate how this affects the rhythmic expression of clock genes and the impact on processes such as metabolism, hormonal cycles, and cellular repair mechanisms. This inhibition also enables researchers to study how circadian disruption influences behavior, sleep patterns, and physiological responses to environmental cues like light and temperature. Additionally, MOP-3 inhibitors provide insights into the interactions between MOP-3/BMAL1 and other proteins in the circadian network, revealing the complex regulatory circuits that ensure precise timing in biological systems. Through these studies, the use of MOP-3 inhibitors enhances our understanding of the fundamental role of circadian regulation in health, development, and cellular homeostasis.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
Dexamethasone may downregulate MOP-3 expression by activating glucocorticoid receptors that bind to promoter regions of circadian genes, leading to transcriptional repression. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin could decrease MOP-3 expression by increasing intracellular cAMP, which may initiate a cascade that culminates in the inhibition of transcription factors essential for MOP-3 gene transcription. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride may reduce MOP-3 expression through the inhibition of GSK-3, a kinase that phosphorylates transcription factors controlling the expression of MOP-3. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid might decrease MOP-3 levels by binding to retinoic acid receptors that heterodimerize with retinoid X receptors, possibly leading to repression of MOP-3 transcription. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium butyrate can lead to a reduction in MOP-3 expression by inhibiting histone deacetylase, resulting in hyperacetylation of histones and suppression of gene transcription machinery. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A may cause a decrease in MOP-3 levels by inhibiting histone deacetylase activity, leading to altered chromatin accessibility and transcriptional silencing of the MOP-3 gene. | ||||||
Ketoconazole | 65277-42-1 | sc-200496 sc-200496A | 50 mg 500 mg | $62.00 $260.00 | 21 | |
Ketoconazole may indirectly suppress MOP-3 expression by inhibiting cytochrome P450 enzymes, thereby altering the synthesis of steroids that control circadian gene expression. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
Valproic acid could lead to decreased MOP-3 expression by inhibiting histone deacetylase, which may cause an accumulation of acetylated histones and suppressive chromatin conformation. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine can decrease MOP-3 expression by inhibiting DNA methyltransferase, reducing methylation levels of the MOP-3 gene promoter, which can lead to transcriptional repression. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $43.00 $65.00 $200.00 $815.00 | 6 | |
Nicotinamide might downregulate MOP-3 by inhibiting the activity of sirtuins, a class of deacetylases, altering the acetylation status of proteins that control MOP-3 gene expression. | ||||||